Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01273610
Title Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Duarte California 91010 United States Details
City of Hope Antelope Valley Lancaster California 93534 United States Details
South Pasadena Cancer Center Pasadena California 91030 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill North Carolina 27599 United States Details
Duke University Medical Center Durham North Carolina 27704 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field